BE0068-5MG
| InVivoMab anti-mouse MHC Class II (I-Ak, I-Ar, I-Af, I-As,I-Ag7)
| 5 mg
| BioXCell
| in vitro MHC class II I-A blocking, in vitro MHC c
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
BE0045-5MG
| InVivoMab anti-mouse IL-4
| 5 mg
| BioXCell
| in vitro IL-4 neutralization, in vivo IL-4 neutral
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0043-1-50MG
| InVivoMab anti-mouse IL-2
| 50 mg
| BioXCell
| in vivo IL-2 neutralization, in vivo IL-2 receptor
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0066-1MG
| InVivoMab anti-mouse Thy1.2 (CD90.2)
| 1 mg
| BioXCell
| in vivo ILC depletion, in vivo T cell depletion
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0003-2-25MG
| InVivoMab anti-human CD4
| 25 mg
| BioXCell
| in vitro T cell stimulatioN/Activation, in vivo CD
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
BE0001-1FAB 50MG
| InVivoMab anti-mouse CD3? F(ab')2 fragment
| 50 mg
| BioXCell
| in vivo T cell depletion
|
| Hamster
| Mouse
| Solicitar Precio
| Solicitar
|
BE0003-1-50MG
| InVivoMab anti-mouse CD4
| 50 mg
| BioXCell
| in vivo CD4+ T cell depletion, Flow cytometry
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0049-1MG
| InVivoMab anti-mouse IL-10
| 1 mg
| BioXCell
| in vivo IL-10 neutralization, in vitro IL-10 neutr
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0000-50MG
| InVivoMab anti-mouse CD1d (CD1.1)
| 50 mg
| BioXCell
| in vivo CD1d neutralization, in vitro CD1d neutral
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0033-2-1MG
| InVivoMab anti-mouse PD-1 (CD279)
| 1 mg
| BioXCell
| in vivo blocking of PD-1/PD-L signaling, in vitro
|
| Armenian hamster
| Mouse
| Solicitar Precio
| Solicitar
|
BE0023-1MG
| InVivoMab anti-human CD71
| 1 mg
| BioXCell
| Flow cytometry, Immunohistochemistry (frozen), Imm
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
BE0011-50MG
| InVivoMab anti-mouse CD22
| 50 mg
| BioXCell
| in vivo B cell depletion in combination with anti-
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
BE0004-2-50MG
| InVivoMab anti-human CD8?
| 50 mg
| BioXCell
| in vivo CD8+ T cell depletion in humanized mice
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
BE0085-100MG
| InVivoMab mouse IgG2a isotype control
| 100 mg
| BioXCell
|
|
| Mouse
| N/
| Solicitar Precio
| Solicitar
|
BE0046-5MG
| InVivoMab anti-mouse IL-6
| 5 mg
| BioXCell
| in vivo IL-6 neutralization, in vitro IL-6 neutral
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0048-5MG
| InVivoMab anti-mouse/human IL-7
| 5 mg
| BioXCell
| in vivo IL-7 neutralization, in vivo IL-7 receptor
|
| Mouse
| mouse/huma
| Solicitar Precio
| Solicitar
|
BE0051-1MG
| InVivoMab anti-mouse IL-12 p40
| 1 mg
| BioXCell
| in vivo IL-12p40 neutralization, p40 affinity chr
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0079-100MG
| InVivoMab anti-human MHC Class I (HLA-A, HLA-B, HLA-C)
| 100 mg
| BioXCell
| Functional assays
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
BE0046-1MG
| InVivoMab anti-mouse IL-6
| 1 mg
| BioXCell
| in vivo IL-6 neutralization, in vitro IL-6 neutral
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0027-25MG
| InVivoMab anti-mouse CD106 (VCAM-1)
| 25 mg
| BioXCell
| in vivoVCAM-1 neutralization, Immunofluorescence
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0060-25MG
| InVivoMab anti-mouse VEGFR-2
| 25 mg
| BioXCell
| in vivo blocking of VEGF/VEGFR-2 signaling, in vit
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0003-3-50MG
| InVivoMab anti-mouse CD4
| 50 mg
| BioXCell
| in vivo blockade of CD4+ T-cell responses, Western
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0086-100MG
| InVivoMab mouse IgG2b isotype control
| 100 mg
| BioXCell
|
|
| Mouse
| N/
| Solicitar Precio
| Solicitar
|
BE0033-2-100MG
| InVivoMab anti-mouse PD-1 (CD279)
| 100 mg
| BioXCell
| in vivo blocking of PD-1/PD-L signaling, in vitro
|
| Armenian hamster
| Mouse
| Solicitar Precio
| Solicitar
|
BE0011-25MG
| InVivoMab anti-mouse CD22
| 25 mg
| BioXCell
| in vivo B cell depletion in combination with anti-
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
BE0019-1-50MG
| InVivoMab anti-human CD47
| 50 mg
| BioXCell
| in vitro CD47 neutralization, iin vivo CD47 neutra
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
BE0045-100MG
| InVivoMab anti-mouse IL-4
| 100 mg
| BioXCell
| in vitro IL-4 neutralization, in vivo IL-4 neutral
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0062-25MG
| InVivoMab anti-mouse/human Integrin ?7
| 25 mg
| BioXCell
| in vivo blocking of integrin ?7, Immunoprecipitat
|
| Rat
| mouse/huma
| Solicitar Precio
| Solicitar
|
BE0061-25MG
| InVivoMab anti-mouse CD8?
| 25 mg
| BioXCell
| in vivo CD8+ T cell depletion
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0058-50MG
| InVivoMab anti-mouse TNF?
| 50 mg
| BioXCell
| in vivo TNF? neutralization, in vitro TNF? neutral
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0020-2-1MG
| InVivoMab anti-human CD54 (ICAM-1)
| 1 mg
| BioXCell
| in vitro T cell stimulatioN/Activation, Immunofluo
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
BE0012-5MG
| InVivoMab anti-mouse CD25 (IL-2R?)
| 5 mg
| BioXCell
| in vivo regulatory T cell depletion, Flow cytometr
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0015-5-1MG
| InVivoMab anti-mouse CD28
| 1 mg
| BioXCell
| in vitro T cell stimulatioN/Activation
|
| Armenian hamster
| Mouse
| Solicitar Precio
| Solicitar
|
BE0066-25MG
| InVivoMab anti-mouse Thy1.2 (CD90.2)
| 25 mg
| BioXCell
| in vivo ILC depletion, in vivo T cell depletion
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0005-1-50MG
| InVivoMab anti-mouse LFA-1? (CD11a)
| 50 mg
| BioXCell
| in vivo LFA-1 neutralization
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0046-25MG
| InVivoMab anti-mouse IL-6
| 25 mg
| BioXCell
| in vivo IL-6 neutralization, in vitro IL-6 neutral
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0070-5MG
| InVivoMab anti-mouse TCR ?/?
| 5 mg
| BioXCell
| in vivo TCR ?/? neutralization, in vitro ?/? T cel
|
| Armenian hamster
| Mouse
| Solicitar Precio
| Solicitar
|
BE0015-5-100MG
| InVivoMab anti-mouse CD28
| 100 mg
| BioXCell
| in vitro T cell stimulatioN/Activation
|
| Armenian hamster
| Mouse
| Solicitar Precio
| Solicitar
|
BE0003-1-100MG
| InVivoMab anti-mouse CD4
| 100 mg
| BioXCell
| in vivo CD4+ T cell depletion, Flow cytometry
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0024-1MG
| InVivoMab anti-mouse CD80 (B7-1)
| 1 mg
| BioXCell
| In vivo CD80 blockade, Flow cytometry
|
| Armenian hamster
| Mouse
| Solicitar Precio
| Solicitar
|
BE0007-100MG
| InVivoMab anti-mouse/human CD11b
| 100 mg
| BioXCell
| in vivo CD11b neutralization, ILC2 cell purificati
|
| Rat
| mouse/huma
| Solicitar Precio
| Solicitar
|
BE0076-100MG
| InVivoMab anti-mouse Thy1 (CD90)
| 100 mg
| BioXCell
| in vitro T cell depletion
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0034-25MG
| InVivoMab anti-mouse LPAM-1 (Integrin ?4?7)
| 25 mg
| BioXCell
| in vivo Integrin ?4?7 neutralization, Flow cytomet
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0028-50MG
| InVivoMab anti-mouse ICOSL (CD275)
| 50 mg
| BioXCell
| in vivo ICOSL neutralization
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0049-50MG
| InVivoMab anti-mouse IL-10
| 50 mg
| BioXCell
| in vivo IL-10 neutralization, in vitro IL-10 neutr
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0016-2-50MG
| InVivoMab anti-mouse CD40
| 50 mg
| BioXCell
| in vivo CD40 activation, in vitro B cell stimulati
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0023-5MG
| InVivoMab anti-human CD71
| 5 mg
| BioXCell
| Flow cytometry, Immunohistochemistry (frozen), Imm
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
BE0032-1MG
| InVivoMab anti-mouse CTLA-4 (CD152)
| 1 mg
| BioXCell
| in vivo CTLA-4 neutralization, in vitro CTLA-4 neu
|
| Armenian hamster
| Mouse
| Solicitar Precio
| Solicitar
|
BE0020-1-25MG
| InVivoMab anti-mouse CD54 (ICAM-1)
| 25 mg
| BioXCell
| In vivo ICAM-1 neutralization
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0072-1MG
| InVivoMab anti-mouse T15 VH and T15 VL regions of IgM
| 1 mg
| BioXCell
| ELISA
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|